首页 > 市场调查报告书 > 医疗设备

整形外科

市场调查报告书

商品编码

1593528

人工骨替代材料市场规模、份额和成长分析（按材料类型、应用、最终用户和地区）：产业预测（2024-2031）

Bone Graft Substitutes Market Size, Share, Growth Analysis, By Material Type (Allograft, Synthetic), By Application (Craniomaxillofacial, Joint Reconstruction), By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年11月10日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球骨移植及其替代品市场规模估值为12亿美元，从2023年的12.8亿美元增长到2031年的21.5亿美元，预计在预测期内增长（2024年预计复合年增长率为2031年至2031 年期间将成长6.70%。

由于合成替代品的日益普及以及监管机构核准的创新产品的推出，全球人工骨替代材料市场预计将出现强劲增长。特别是，百特于 2020 年 7 月获得 FDA 批准的 Altapore Shape 生物活性骨移植物反映了这一趋势。骨移植物及其替代品的使用由于其生物相容性、安全性和促进骨癒合而越来越受到青睐，这凸显了对最大限度地减少副作用的生物相容性解决方案的需求正在迅速增加。合成植入物，尤其是那些注射到羟磷石灰(HAp) 和磷酸三钙 (TCP) 的植入物，由于其高相容性而成为流行的替代品。例如，Graftys 认证的骨空隙填充剂以及 Molecular Matrix 推出先进的 Osteo-P 合成骨移植替代品。其他好处包括更快的恢復时间、更短的住院时间和更小的切口。美国整形外科学会（AAOS）的资料显示，关节镜手术、脊椎手术、骨折修復、全关节重建等微创整形外科手术在美国稳定成长，而这些手术都人工骨替代材料。市场成长。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲
中东和非洲 (MEA)
- 波湾合作理事会(GCC) 国家
- 南非
- 其他中东/非洲

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

AlloSource（美国）
史密斯+侄子（英国）
Medtronic (Ireland)
Orthofix US LLC（美国）
Pietro Fiorentini SpA（义大利）
TBF（法国）
OST 实验室（法国）
盖氏製药股份公司（瑞士）
史赛克（美国）
生物银行（英国）
爱知时计电机株式会社（日本）
重庆山城燃气设备有限公司 (中国)
Flonidan A/S（丹麦）
EMH 计量有限公司 (德国)
Badger Meter, Inc.（美国）
威胜集团控股有限公司（星宝投资控股有限公司）（中国）
华立科技有限公司（华立集团）（中国）
前卫克罗姆施罗德仪表有限公司 (中国)
安全仪表有限公司（印度）
IMAC 系统公司（美国）
Metrix 仪表（波兰）

简介目录

Product Code: SQMIG35A2257

Global Bone Grafts and Substitutes Market size was valued at USD 1.2 billion in 2022 and is poised to grow from USD 1.28 billion in 2023 to USD 2.15 billion by 2031, growing at a CAGR of 6.70% during the forecast period (2024-2031).

The global market for bone graft substitutes is poised for robust growth driven by the rising preference for synthetic substitutes and the introduction of innovative products approved by regulatory bodies. Notably, Baxter's FDA clearance in July 2020 for its Altapore Shape Bioactive Bone Graft exemplifies this trend. The incorporation of bone grafts and substitutes is increasingly favored due to their biocompatibility, safety profile, and promotion of bone healing, with a notable surge in demand for biocompatible solutions that minimize adverse reactions. Synthetic grafts, particularly those infused with Hydroxyapatite (HAp) and Tricalcium Phosphate (TCP), have emerged as popular alternatives due to their enhanced compatibility. Regulatory support and proactive product development strategies by market players are further bolstering market expansion, highlighted by Graftys' certification of its bone void fillers and Molecular Matrix's launch of the advanced Osteo-P Synthetic Bone Graft Substitute. Additionally, the trend toward minimally invasive procedures enhances the demand for bone grafts due to benefits such as reduced recovery time, shorter hospital stays, and smaller incisions. Data from the American Academy of Orthopedic Surgeons (AAOS) indicates a steady rise in minimally invasive orthopedic procedures in the United States, including arthroscopy, spine surgeries, fracture repairs, and joint replacements, all of which significantly contribute to the accelerated growth of the bone graft substitute market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bone Grafts And Substitutes market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bone Grafts And Substitutes Market Segmental Analysis

Global Bone Grafts and Substitutes Market is segmented by Material Type, Application, End User and Region. Based on Material Type, the market is segmented into Allograft, Synthetic. Based on Application, the market is segmented into Craniomaxillofacial, Dental, Foot & Ankle, Joint Reconstruction, Long Bone, and Spinal Fusion. Based on End User, the market is segmented into Hospitals, Specialty clinics, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Bone Grafts And Substitutes Market

A key market driver for the global bone grafts and substitutes market is the rising prevalence of orthopedic conditions and musculoskeletal disorders, fueled by factors such as sedentary lifestyles, an aging population, and a surge in sports-related injuries and accidents. The increasing incidence of fractures and bone-related ailments has escalated the demand for effective bone graft substitutes that facilitate bone regeneration and healing processes. This growing need emphasizes the urgency for innovative and efficient solutions within the market, aimed at addressing the burgeoning patient population and the complexities associated with a variety of orthopedic conditions, thereby driving market growth and development.

Restraints in the Global Bone Grafts And Substitutes Market

A significant market restraint for the global bone grafts and substitutes market is the high cost associated with these advanced medical products. The utilization of sophisticated technologies and premium materials in developing bone graft substitutes drives their prices up, which can limit their adoption, particularly in emerging economies where healthcare budgets are constrained. Furthermore, inadequate reimbursement coverage for these products within various healthcare systems exacerbates the issue, resulting in reduced accessibility for potential patients. This financial barrier presents a considerable challenge for individuals, healthcare practitioners, and systems striving for cost-effective solutions in managing bone-related ailments, thereby impacting overall market growth.

Market Trends of the Global Bone Grafts And Substitutes Market

The global bone grafts and substitutes market is witnessing a significant trend towards the development of bioactive and tissue-engineered grafts, driven by the need for enhanced biocompatibility and accelerated bone healing. Innovations in technologies like 3D printing and nanotechnology are facilitating the production of tailored graft substitutes that boast superior structural and mechanical properties. This trend underscores the industry's focus on pioneering solutions that closely resemble natural bone tissue, yielding better patient outcomes and minimizing complications associated with traditional bone grafting techniques. As a result, the market is evolving towards more advanced and effective graft options, reflecting a commitment to improving surgical results and patient recovery.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Value Chain Analysis
Ecosystem of the Market
Case study Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Bone Graft Substitutes Market by Material Type

Market Overview
Allograft
- Demineralized Bone Matrix
- Others
Synthetic
- Ceramics
- HAP
- B-TCP
- a-TCP
- Bi-phasic Calcium Phosphates (BCP)
- Others
- Composites
- Polymers
- Bone Morphogenic Proteins (BMP)

Bone Graft Substitutes Market by Application

Market Overview
Craniomaxillofacial
Dental
Foot & Ankle
Joint Reconstruction
Long Bone
Spinal Fusion

Bone Graft Substitutes Market by End User

Market Overview
Hospitals
Specialty clinics
Others

Bone Graft Substitutes Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

AlloSource (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith + Nephew (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthofix US LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pietro Fiorentini S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TBF (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OST Laboratories (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Geistlich Pharma AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biobank (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aichi Tokei Denki Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chongqing Shancheng Gas Equipment Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Flonidan A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EMH metering GmbH & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Badger Meter, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wasion Group Holdings Limited (Star Treasure Investments Holdings Limited) (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Holley Technology Ltd. (Holley Group) (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qianwei Kromschroder Meters Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Secure Meters Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IMAC Systems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Metrix Meter (Poland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments